Labcorp forward PE LH

Share price divided by analysts' consensus earnings for the next twelve months, since 1998.

Today, Oct 23, 2026: 17.4×
10-year median: 13.3×
Against its 10-year history: 99th; percentile: 0 is its lowest day, 100 its highest
10-year range: 5.6× to 17.8×
Peer median: 31.5×

Labcorp's forward PE is 17.4× as of Oct 23, 2026.

That is above its ten-year median of 13.3×, higher than on 99% of days in the last ten years.

Over that time it ranged from 5.6× in Mar 2020 to 17.8× in Aug 2026.

The median for 10 diagnostics and research stocks of a similar size is 31.5×.

Forward PE over time

median 13.3×

The dashed line is the 10-year median and the shaded band the middle half of its days.

Open the interactive chart, with overlays and comparisons

Year by year

Year	End of year	Low	High
2026 so far	17.4×	13.5×	17.8×
2025	14.5×	13.6×	16.9×
2024	14.9×	13.6×	16.2×
2023	16.2×	11.4×	16.2×
2022	12.3×	10.2×	13.1×
2021	12.7×	7.0×	12.7×
2020	6.7×	5.6×	13.9×
2019	12.9×	10.2×	16.9×
2018	9.9×	9.9×	14.9×
2017	12.8×	12.1×	14.2×
2016	12.3×	10.4×	13.5×
2015	12.5×	11.7×	14.5×
2014	13.0×	11.2×	13.8×
2013	11.5×	10.6×	13.4×
2012	10.6×	10.1×	12.1×
2011	11.2×	10.4×	13.7×
2010	12.8×	11.1×	13.0×
2009	12.4×	10.3×	12.6×
2008	12.0×	10.2×	15.2×
2007	14.4×	13.2×	18.8×

Against its peers

Companies in Medical - Diagnostics & Research nearest Labcorp's size, closest first, today.

Company	Forward PE
LHLabcorp	17.4×
DGXQuest Diagnostics	n/m
MTDMettler-Toledo International	33.9×
MEDPMedpace	n/m
RVTYRevvity	n/m
ILMNIllumina	47.2×
IDXXIDEXX Laboratories	35.9×
WATWaters	29.2×
IQVIQVIA	20.5×
AAgilent Technologies	26.4×
BIOBio-Rad Laboratories	n/m
Peer median	31.5×

Where Labcorp ranks

#19of 51Healthcare stocks with the lowest forward PE

What the forward PE tells you

Price divided by what analysts expect the company to earn over the next twelve months. It answers "what am I paying for next year" instead of last year.

Estimates are opinions. When forward PE is far below trailing PE, analysts expect a big jump in earnings. If that jump slips, the stock was not as cheap as it looked.

More on Labcorp

Valuation data, not investment advice. Prices as of Oct 23, 2026. Reported figures come from the company's filings with the SEC.